These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6198519)

  • 1. Design, synthesis, and X-ray data of novel potential antipsychotic agents. Substituted 7-phenylquinolizidines: stereospecific, neuroleptic, and antinociceptive properties.
    Imhof R; Kyburz E; Daly JJ
    J Med Chem; 1984 Feb; 27(2):165-75. PubMed ID: 6198519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
    Meltzer HY; Paul SM; Fang VS
    Psychopharmacology (Berl); 1977 Jan; 51(2):181-3. PubMed ID: 14352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds.
    Bruderlein FT; Humber LG
    J Med Chem; 1975 Feb; 18(2):185-8. PubMed ID: 1168258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ; Spuhler K; Prasad KN; Seeman P
    Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
    [No Abstract]   [Full Text] [Related]  

  • 9. The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agents.
    Wright JL; Caprathe BW; Downing DM; Glase SA; Heffner TG; Jaen JC; Johnson SJ; Kesten SR; MacKenzie RG; Meltzer LT
    J Med Chem; 1994 Oct; 37(21):3523-33. PubMed ID: 7932581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Substituted 1-azabicycloalkanes, a new class of non-opiate antinociceptive agents.
    Carson JR; Carmosin RJ; Vaught JL; Gardocki JF; Costanzo MJ; Raffa RB; Almond HR
    J Med Chem; 1992 Jul; 35(15):2855-63. PubMed ID: 1495016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors.
    Chrzanowski FA; McGrogan BA; Maryanoff BE
    J Med Chem; 1985 Mar; 28(3):399-400. PubMed ID: 2579238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.
    Minor DL; Wyrick SD; Charifson PS; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1994 Dec; 37(25):4317-28. PubMed ID: 7996543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational properties of butaclamol and isobutaclamol. Regularities in the structures of semirigid neuroleptics.
    Froimowitz M; Matthysse S
    Mol Pharmacol; 1983 Sep; 24(2):243-50. PubMed ID: 6193405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted benzamides with conformationally restricted side chains. 1. Quinolizidine derivatives as selective gastric prokinetic agents.
    Hadley MS; King FD; McRitchie B; Turner DH; Watts EA
    J Med Chem; 1985 Dec; 28(12):1843-7. PubMed ID: 4068007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
    Wilson J; Lin H; Fu D; Javitch JA; Strange PG
    J Neurochem; 2001 Apr; 77(2):493-504. PubMed ID: 11299312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational properties of semirigid antipsychotic drugs: the pharmacophore for dopamine D-2 antagonist activity.
    Froimowitz M; Rämsby S
    J Med Chem; 1991 May; 34(5):1707-14. PubMed ID: 1674541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of 2-sulfonamido-1,3,4,6,7,11b alpha-hexahydro-2H-benzo[a]quinolizines as alpha 2-adrenoceptor antagonists.
    Ward TJ; White JF; Lattimer N; Rhodes KF; Sharma S; Waterfall JF
    J Med Chem; 1988 Jul; 31(7):1421-6. PubMed ID: 2838634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidopaminergic effects of the stereoisomers of N-[(1-alkyl-2- pyrrolidinyl)methyl]-5-sulfamoylbenzamides and -2,3-dihydrobenzofuran-7-carboxamides.
    Murakami S; Marubayashi N; Fukuda T; Takehara S; Tahara T
    J Med Chem; 1991 Jan; 34(1):261-7. PubMed ID: 1825115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
    Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
    J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute configuration of potentially neuroleptic rigid spiro amines. A study on the topography of the neuroleptic receptor.
    Carnmalm B; Johansson L; Rämsby S; Stjernström NE; Wägner A
    Acta Pharm Suec; 1979; 16(4):239-46. PubMed ID: 44421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.